Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autoimmune form of thrombocytopenia.
Biomarker and diagnostic research for autoimmune thrombocytopenia has been reported in the published literature.
52 clinical trials registered, 34 recruiting. Interventions under study include drug therapy, other interventions, biologic therapy, and procedural interventions. Pipeline includes 2 PHASE4, 4 PHASE3, 20 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT04005638](https://clinicaltrials.gov/study/NCT04005638) |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 3:00 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia |
— |
University Hospital, Bordeaux |
RECRUITING |
[NCT02877706](https://clinicaltrials.gov/study/NCT02877706) | French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia | — | University Hospital, Toulouse | RECRUITING |
[NCT06838962](https://clinicaltrials.gov/study/NCT06838962) | Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP) | PHASE2 | Institute of Hematology & Blood Diseases Hospital, China | RECRUITING |
[NCT07362199](https://clinicaltrials.gov/study/NCT07362199) | Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) | PHASE2 | Institute of Hematology & Blood Diseases Hospital, China | RECRUITING |
[NCT06776510](https://clinicaltrials.gov/study/NCT06776510) | A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia | PHASE1 | Institute of Hematology & Blood Diseases Hospital, China | RECRUITING |
32 publications have been identified in PubMed for autoimmune thrombocytopenia. Research spans Case Report / Case Series (50%), Basic Science / Preclinical (19%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 16 | 50% |
Laboratory research | 6 | 19% |
Disease patterns and progression | 4 | 13% |
Clinical study results | 3 | 9% |
Research summaries | 2 | 6% |
Testing and diagnosis research | 1 | 3% |
Alexandre J (2026). [PMID: 41654471](https://pubmed.ncbi.nlm.nih.gov/41654471/). *Annales de chirurgie plastique et esthetique*. [Case Report / Case Series]
Tribolet de Abreu I (2026). [PMID: 41017637](https://pubmed.ncbi.nlm.nih.gov/41017637/). *Acta medica portuguesa*. [Case Report / Case Series]
Alizadeh Saadooni S (2026). [PMID: 41492332](https://pubmed.ncbi.nlm.nih.gov/41492332/). *Health science reports*. [Case Report / Case Series]
Jankowski J (2026). [PMID: 41684006](https://pubmed.ncbi.nlm.nih.gov/41684006/). *International journal of molecular sciences*. [Basic Science / Preclinical]
Ullah I (2026). [PMID: 41675911](https://pubmed.ncbi.nlm.nih.gov/41675911/). *Annals of medicine and surgery (2012)*. [Epidemiology / Natural History]
Shahzeb M (2026). [PMID: 41640928](https://pubmed.ncbi.nlm.nih.gov/41640928/). *Cureus*. [Case Report / Case Series]
Cooper N (2026). [PMID: 41943179](https://pubmed.ncbi.nlm.nih.gov/41943179/). *Am J Hematol*. [Clinical Trial Publication]
Chung SW (2025). [PMID: 40364121](https://pubmed.ncbi.nlm.nih.gov/40364121/). *Journal of clinical medicine*. [Case Report / Case Series]
Venkatachari M (2025). [PMID: 40268699](https://pubmed.ncbi.nlm.nih.gov/40268699/). *BMJ case reports*. [Case Report / Case Series]
Li T (2025). [PMID: 41267080](https://pubmed.ncbi.nlm.nih.gov/41267080/). *Cell communication and signaling : CCS*. [Basic Science / Preclinical]